Skip to content

BacLite Rapid MRSA Clinical Performance

BacLite Rapid MRSA Clinical Performance

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00541632
Enrollment
Unknown
Registered
2007-10-10
Start date
2007-10-31
Completion date
2008-03-31
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methicillin Resistance

Brief summary

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Interventions

None listed

Sponsors

3M
CollaboratorINDUSTRY
Solventum US LLC
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects 18 years or older * Subjects willing to document demographic characteristics * Subjects willing to have their nose swabbed * Subjects (or legal representative) willing to sign consent and authorization forms

Exclusion criteria

* Subjects who use Vicks Sinex Nasal spray or other nasal sprays * Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects * Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares * Investigator believes that subject is unsuitable for inclusion.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026